Amdocs added to Dividend Growth Model Portfolio, highlighting dividend reliability and growth. Generated $2.9B FCF (2019–3Q25) versus $1.3B dividends paid, showing strong coverage. Quarterly dividend rose from $0.29 to $0.53; annualized yield ~2.5%. PEBV=1.0 implies zero NOPAT growth priced in; model scenario implies $98 fair value (17% upside).
Amdocs' Q4 earnings report set for Nov. 11, predicting $1.82 per share. Quarterly revenue expected at $1.15 billion, down from $1.26 billion last year. Signed multi-year agreement for enhanced managed transformation using AI offerings. Shares rose 1.1% to close at $85.49 recently. Several analysts maintain positive ratings despite slight changes in price targets.